The impact of leishmaniasis on mental health and psychosocial well-being: A systematic review.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
04
05
2019
accepted:
18
09
2019
entrez:
18
10
2019
pubmed:
18
10
2019
medline:
17
3
2020
Statut:
epublish
Résumé
Leishmaniasis is a neglected tropical parasitic disease endemic in South Asia, East Africa, Latin America and the Middle East. It is associated with low socioeconomic status (SES) and responsible for considerable mortality and morbidity. Reports suggest that patients with leishmaniasis may have a higher risk of mental illness (MI), psychosocial morbidity (PM) and reduced quality of life (QoL), but this is not well characterised. The aim of this study was to conduct a systematic review to assess the reported impact of leishmaniasis on mental health and psychosocial wellbeing. A systematic review of the literature was carried out. Pre-specified criteria were applied to identify publications including observational quantitative studies or systematic reviews. Two reviewers screened all of the titles, abstracts and full-studies and a third reviewer was consulted for disagreements. Data was extracted from papers meeting the criteria and quality appraisal of the methods was performed using the Newcastle-Ottawa Scale or the Risk of Bias in Systematic Review tool. A total of 14 studies were identified from 12,517 records. Nine cross-sectional, three case-control, one cohort study and one systematic review were included. Eleven assessed MI outcomes and were measured with tools specifically designed for this; nine measured PM and 12 measured QoL using validated measurement tools. Quality appraisal of the studies showed that six were of good quality. Cutaneous leishmaniasis and post kala-azar dermal leishmaniasis showed evidence of associated MI and PM including depression, anxiety and stigma, while all forms of disease showed decreased QoL. The findings were used to inform a proposed model and conceptual framework to show the possible links between leishmaniasis and mental health outcomes. There is evidence that leishmaniasis has an impact on MI, PM or QoL of patients and their families and this occurs in all the main subtypes of the disease. There are however large gaps in the evidence. Further research is required to understand the full extent of this problem and its mechanistic basis.
Sections du résumé
BACKGROUND
Leishmaniasis is a neglected tropical parasitic disease endemic in South Asia, East Africa, Latin America and the Middle East. It is associated with low socioeconomic status (SES) and responsible for considerable mortality and morbidity. Reports suggest that patients with leishmaniasis may have a higher risk of mental illness (MI), psychosocial morbidity (PM) and reduced quality of life (QoL), but this is not well characterised. The aim of this study was to conduct a systematic review to assess the reported impact of leishmaniasis on mental health and psychosocial wellbeing.
METHODS
A systematic review of the literature was carried out. Pre-specified criteria were applied to identify publications including observational quantitative studies or systematic reviews. Two reviewers screened all of the titles, abstracts and full-studies and a third reviewer was consulted for disagreements. Data was extracted from papers meeting the criteria and quality appraisal of the methods was performed using the Newcastle-Ottawa Scale or the Risk of Bias in Systematic Review tool.
RESULTS
A total of 14 studies were identified from 12,517 records. Nine cross-sectional, three case-control, one cohort study and one systematic review were included. Eleven assessed MI outcomes and were measured with tools specifically designed for this; nine measured PM and 12 measured QoL using validated measurement tools. Quality appraisal of the studies showed that six were of good quality. Cutaneous leishmaniasis and post kala-azar dermal leishmaniasis showed evidence of associated MI and PM including depression, anxiety and stigma, while all forms of disease showed decreased QoL. The findings were used to inform a proposed model and conceptual framework to show the possible links between leishmaniasis and mental health outcomes.
CONCLUSION
There is evidence that leishmaniasis has an impact on MI, PM or QoL of patients and their families and this occurs in all the main subtypes of the disease. There are however large gaps in the evidence. Further research is required to understand the full extent of this problem and its mechanistic basis.
Identifiants
pubmed: 31622369
doi: 10.1371/journal.pone.0223313
pii: PONE-D-19-24670
pmc: PMC6797112
doi:
Types de publication
Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0223313Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P024661/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT1063203
Pays : United Kingdom
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Soc Sci Med. 2016 Feb;151:139-46
pubmed: 26802370
Int Rev Psychiatry. 2017 Oct;29(5):389-402
pubmed: 28753076
East Afr Med J. 1953 Jul;30(7):287-93
pubmed: 13095327
Compr Psychiatry. 2012 Oct;53(7):940-5
pubmed: 22497671
J Clin Endocrinol Metab. 2005 May;90(5):2522-30
pubmed: 15705924
J Trop Med. 2011;2011:359145
pubmed: 22174721
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Cochrane Database Syst Rev. 2012 Nov 14;11:CD007064
pubmed: 23152241
BMC Public Health. 2018 Mar 15;18(1):358
pubmed: 29544463
Int Health. 2010 Mar;2(1):69-74
pubmed: 24037054
Psychiatry Res. 2015 Sep 30;229(1-2):27-36
pubmed: 26187338
BMC Med. 2019 Feb 15;17(1):13
pubmed: 30764817
Psychosom Med. 2009 Feb;71(2):171-86
pubmed: 19188531
Am J Trop Med Hyg. 2018 Mar;98(3):857-863
pubmed: 29280426
Brain Behav Immun. 2009 Oct;23(7):936-44
pubmed: 19416750
PLoS One. 2017 Dec 20;12(12):e0189906
pubmed: 29261762
Rev Soc Bras Med Trop. 2010 Nov-Dec;43(6):743-5
pubmed: 21181038
J Affect Disord. 2018 Feb;227:494-497
pubmed: 29156363
Trans R Soc Trop Med Hyg. 1985;79(6):872
pubmed: 3832498
Am J Trop Med Hyg. 2017 Apr;96(4):802-804
pubmed: 28115678
Lancet. 1991 Nov 2;338(8775):1142
pubmed: 1682557
Trans R Soc Trop Med Hyg. 2013 May;107(5):335-6
pubmed: 23474473
Biomed Res Int. 2014;2014:739650
pubmed: 25309921
Curr Opin Infect Dis. 2015 Oct;28(5):426-37
pubmed: 26312442
Arch Intern Med. 2004 May 10;164(9):1010-4
pubmed: 15136311
Health Qual Life Outcomes. 2017 Aug 30;15(1):65
pubmed: 28851361
Parasit Vectors. 2012 Feb 09;5:31
pubmed: 22316234
Arch Iran Med. 2013 Aug;16(8):474-7
pubmed: 23906253
PLoS Negl Trop Dis. 2008 May 14;2(5):e237
pubmed: 18478049
Am J Trop Med Hyg. 1996 Dec;55(6):652-4
pubmed: 9025693
J Clin Epidemiol. 2016 Jan;69:225-34
pubmed: 26092286
Curr Psychiatry Rep. 2013 Oct;15(10):400
pubmed: 23975043
PLoS Negl Trop Dis. 2016 Oct 27;10(10):e0005090
pubmed: 27788184
BMC Med. 2013 Sep 12;11:200
pubmed: 24228900
Am J Trop Med Hyg. 2018 Mar;98(3):747-752
pubmed: 29363454
Parasite Immunol. 2011 Jun;33(6):330-4
pubmed: 21332759
PLoS One. 2012;7(5):e35671
pubmed: 22693548
PLoS Negl Trop Dis. 2008;2(10):e259
pubmed: 18958168
J Public Health (Oxf). 2008 Dec;30(4):487-93
pubmed: 18400696
Braz J Med Biol Res. 2003 Apr;36(4):485-9
pubmed: 12700826
Biol Psychiatry. 2010 Mar 1;67(5):446-57
pubmed: 20015486
East Mediterr Health J. 2012 Jan;18(1):7-14
pubmed: 22360005
PLoS Negl Trop Dis. 2019 Feb 25;13(2):e0007092
pubmed: 30802261
Lancet Infect Dis. 2003 Feb;3(2):87-98
pubmed: 12560194
Int Health. 2016 Mar;8 Suppl 1:i53-70
pubmed: 26940310
Am J Trop Med Hyg. 1995 Feb;52(2):149-54
pubmed: 7872442
Eur Cytokine Netw. 2012 Oct-Dec;23(4):179-86
pubmed: 23360798
Clin Exp Dermatol. 2004 Sep;29(5):464-7
pubmed: 15347324
Ann Trop Med Parasitol. 2008 Mar;102(2):185-8
pubmed: 18318942
Emerg Infect Dis. 2005 Apr;11(4):634-6
pubmed: 15834984
Health Qual Life Outcomes. 2017 Jul 24;15(1):148
pubmed: 28738881
Postepy Dermatol Alergol. 2015 Oct;32(5):344-8
pubmed: 26759542
Rev Neurol (Paris). 2003 Nov;159(11):1046-8
pubmed: 14710025
Sci Rep. 2017 Aug 16;7(1):8454
pubmed: 28814754
J Neuroimmunol. 2015 Dec 15;289:21-9
pubmed: 26616868
Infect Dis Poverty. 2017 Apr 7;6(1):46
pubmed: 28385151
Scand J Gastroenterol. 2002 Apr;37(4):450-7
pubmed: 11989837
Transl Psychiatry. 2016 May 31;6(5):e825
pubmed: 27244234
Int J Womens Dermatol. 2016 Jun 16;2(3):93-101
pubmed: 28492018
Am J Trop Med Hyg. 2017 Jan 11;96(1):24-45
pubmed: 27927991
PLoS Negl Trop Dis. 2018 Sep 6;12(9):e0006697
pubmed: 30188898
PLoS One. 2016 Jan 25;11(1):e0147601
pubmed: 26808317
J Am Acad Dermatol. 2015 Dec;73(6):897-908; quiz 909-10
pubmed: 26568335
Front Neurosci. 2014 Oct 07;8:315
pubmed: 25339862
PLoS Negl Trop Dis. 2015 Oct 20;9(10):e0004003
pubmed: 26485128
Am J Trop Med Hyg. 2013 Dec;89(6):1146-1153
pubmed: 24189368